I am an accomplished neuroscientist with over 20 years of executive leadership in neuropharmacology, neuroinflammation, basic and translational science, target identification and validation, and therapeutic development. My career includes groundbreaking contributions to drug discovery and clinical advancements, guiding experimental discoveries into clinical trials, achieving FDA approvals, and securing and managing several hundred million dollars in research and development funding. I founded the Stanford Program for Integrated Neuroscience Technology and the Behavioral and Functional Neuroscience Laboratory, establishing two pioneering organizations dedicated to advancing neuroscience research and therapeutics. My expertise spans the development of innovative platforms for drug discovery, with a particular emphasis on GPCR-targeted therapies for neurological and neuropsychiatric disorders.